Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 May 10;91(10):4485–4488. doi: 10.1073/pnas.91.10.4485

Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia.

R N Pahwa 1, A Fleischer 1, S Than 1, R A Good 1
PMCID: PMC43810  PMID: 8183934

Abstract

Cord blood, a potent source of hematopoietic stem cells, has been shown to successfully reconstitute hematopoiesis following allogeneic transplantation in a variety of disorders. A major drawback of cord blood has been the risk of transfusion reactions in ABO blood group incompatibility and drastic reduction in the stem cell pool if the cord blood is manipulated to remove red cells prior to cryopreservation or after thawing. This report describes an erythrocyte depletion method employing 3% gelatin-induced erythrocyte sedimentation for the selective removal of red cells from cord blood. The red cell-depleted fraction was shown to be enriched in progenitor cells and in cells secreting hematopoietic cytokines interleukin 3, granulocyte/macrophage colony-stimulating factor, and interleukin 6; a major source for cytokines was from cord T cells. This preparative technique was employed to separate out red cells from cord blood of an infant delivered by cesarean section who had an 8-year-old sibling with leukemia. Histocompatibility testing of cord cells revealed complete matching with the patient. A cord cell transplant of cryopreserved and thawed cells consisting of 4 x 10(7) nucleated cells per kg was administered to the patient following myeloablative chemotherapy. The patient's quick hematologic recovery and 9-month disease-free period to date suggest that 3% gelatin separation of erythrocytes is a simple method that can be successfully used for transplanting cord cells for malignant/nonmalignant diseases.

Full text

PDF
4485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broxmeyer H. E., Douglas G. W., Hangoc G., Cooper S., Bard J., English D., Arny M., Thomas L., Boyse E. A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989 May;86(10):3828–3832. doi: 10.1073/pnas.86.10.3828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Broxmeyer H. E., Kurtzberg J., Gluckman E., Auerbach A. D., Douglas G., Cooper S., Falkenburg J. H., Bard J., Boyse E. A. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells. 1991;17(2):313–329. [PubMed] [Google Scholar]
  3. Butturini A., Seeger R. C., Gale R. P. Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood. 1986 Oct;68(4):954–956. [PubMed] [Google Scholar]
  4. Clouse K. A., Cosentino L. M., Weih K. A., Pyle S. W., Robbins P. B., Hochstein H. D., Natarajan V., Farrar W. L. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol. 1991 Nov 1;147(9):2892–2901. [PubMed] [Google Scholar]
  5. Gluckman E., Broxmeyer H. A., Auerbach A. D., Friedman H. S., Douglas G. W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989 Oct 26;321(17):1174–1178. doi: 10.1056/NEJM198910263211707. [DOI] [PubMed] [Google Scholar]
  6. Gluckman E., Thierry D., Traineau R. Blood banking for hematopoietic stem cell transplantation. J Hematother. 1993 Summer;2(2):269–270. doi: 10.1089/scd.1.1993.2.269. [DOI] [PubMed] [Google Scholar]
  7. Harris D. T., Schumacher M. J., Locascio J., Besencon F. J., Olson G. B., DeLuca D., Shenker L., Bard J., Boyse E. A. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10006–10010. doi: 10.1073/pnas.89.21.10006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kalyanaraman V. S., Rodriguez V., Veronese F., Rahman R., Lusso P., DeVico A. L., Copeland T., Oroszlan S., Gallo R. C., Sarngadharan M. G. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1990 Mar;6(3):371–380. doi: 10.1089/aid.1990.6.371. [DOI] [PubMed] [Google Scholar]
  9. Keever C. A. Characterization of cord blood lymphocyte subpopulations. J Hematother. 1993 Summer;2(2):203–206. doi: 10.1089/scd.1.1993.2.203. [DOI] [PubMed] [Google Scholar]
  10. Merrill J. E., Koyanagi Y., Chen I. S. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol. 1989 Oct;63(10):4404–4408. doi: 10.1128/jvi.63.10.4404-4408.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nakajima K., Martínez-Maza O., Hirano T., Breen E. C., Nishanian P. G., Salazar-Gonzalez J. F., Fahey J. L., Kishimoto T. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol. 1989 Jan 15;142(2):531–536. [PubMed] [Google Scholar]
  12. Pollack M. S., Kirkpatrick D., Kapoor N., Dupont B., O'Reilly R. J. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med. 1982 Sep 9;307(11):662–666. doi: 10.1056/NEJM198209093071106. [DOI] [PubMed] [Google Scholar]
  13. Rabian-Herzog C., Lesage S., Gluckman E., Charron D. Characterization of lymphocyte subpopulations in cord blood. J Hematother. 1993 Summer;2(2):255–257. doi: 10.1089/scd.1.1993.2.255. [DOI] [PubMed] [Google Scholar]
  14. Rubinstein P. Placental blood-derived hematopoietic stem cells for unrelated bone marrow reconstitution. J Hematother. 1993 Summer;2(2):207–210. doi: 10.1089/scd.1.1993.2.207. [DOI] [PubMed] [Google Scholar]
  15. Sugiura K., Oyaizu N., Pahwa R., Kalyanaraman V. S., Pahwa S. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood. 1992 Sep 15;80(6):1463–1469. [PubMed] [Google Scholar]
  16. Vilmer E., Sterkers G., Rahimy C., Denamur E., Elion J., Broyart A., Lescoeur B., Tiercy J. M., Gerota J., Blot P. HLA-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation. 1992 May;53(5):1155–1157. [PubMed] [Google Scholar]
  17. Wagner J. E., Broxmeyer H. E., Byrd R. L., Zehnbauer B., Schmeckpeper B., Shah N., Griffin C., Emanuel P. D., Zuckerman K. S., Cooper S. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood. 1992 Apr 1;79(7):1874–1881. [PubMed] [Google Scholar]
  18. Wagner J. E., Broxmeyer H. E., Byrd R. L., Zehnbauer B., Schmeckpeper B., Shah N., Griffin C., Emanuel P. D., Zuckerman K. S., Cooper S. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood. 1992 Apr 1;79(7):1874–1881. [PubMed] [Google Scholar]
  19. Wagner J. E., Jr Umbilical cord blood stem cell transplantation: current status and future prospects (1992). J Hematother. 1993 Summer;2(2):225–228. doi: 10.1089/scd.1.1993.2.225. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES